These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Fidler SJ; Dorrell L; Ball S; Lombardi G; Weber J; Hawrylowicz C; Rees AD Immunology; 1996 Sep; 89(1):46-53. PubMed ID: 8911139 [TBL] [Abstract][Full Text] [Related]
3. CD4+ T-cell recognition of diverse clade B HIV-1 isolates. Fernandez MH; Fidler SJ; Pitman RJ; Weber JN; Rees AD AIDS; 1997 Mar; 11(3):281-8. PubMed ID: 9147418 [TBL] [Abstract][Full Text] [Related]
4. High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120. Baillou A; Brand D; Denis F; M'Boup S; Chout R; Goudeau A; Barin F AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1209-15. PubMed ID: 7511395 [TBL] [Abstract][Full Text] [Related]
5. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993. Sherefa K; Sällberg M; Sönnerborg A AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097 [TBL] [Abstract][Full Text] [Related]
6. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494 [TBL] [Abstract][Full Text] [Related]
7. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition. Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208 [TBL] [Abstract][Full Text] [Related]
8. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades. Gorny MK; Mascola JR; Israel ZR; VanCott TC; Williams C; Balfe P; Hioe C; Brodine S; Burda S; Zolla-Pazner S AIDS Res Hum Retroviruses; 1998 Feb; 14(3):213-21. PubMed ID: 9491911 [TBL] [Abstract][Full Text] [Related]
9. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. Vogel T; Kurth R; Norley S J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220 [TBL] [Abstract][Full Text] [Related]
10. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients. Safrit JT; Lee AY; Andrews CA; Koup RA J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera. Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152 [TBL] [Abstract][Full Text] [Related]
12. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells. Trujillo JR; Rogers RA; Brain JD Virology; 1998 Jun; 246(1):53-62. PubMed ID: 9656993 [TBL] [Abstract][Full Text] [Related]
13. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120. Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346 [TBL] [Abstract][Full Text] [Related]
14. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1. Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988 [TBL] [Abstract][Full Text] [Related]
15. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor. Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359 [TBL] [Abstract][Full Text] [Related]
16. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120. Warren AP; Thomas DB AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202 [TBL] [Abstract][Full Text] [Related]
17. The HIV-1 gp120/V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific transcriptional signature. Morou AK; Porichis F; Krambovitis E; Sourvinos G; Spandidos DA; Zafiropoulos A J Transl Med; 2011 Sep; 9():160. PubMed ID: 21943198 [TBL] [Abstract][Full Text] [Related]
18. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. Vancott TC; Polonis VR; Loomis LD; Michael NL; Nara PL; Birx DL AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1379-91. PubMed ID: 8573396 [TBL] [Abstract][Full Text] [Related]
19. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates. Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151 [TBL] [Abstract][Full Text] [Related]
20. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]